- Home
- CDTX vs NFJ Comparison
CDTX vs NFJ Comparison
Compare CDTX & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- NFJ
- Stock Information
- Founded
- CDTX 2012
- NFJ 2005
- Country
- CDTX United States
- NFJ United States
- Employees
- CDTX N/A
- NFJ N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- NFJ Finance: Consumer Services
- Sector
- CDTX Health Care
- NFJ Finance
- Exchange
- CDTX Nasdaq
- NFJ Nasdaq
- Market Cap
- CDTX 980.1M
- NFJ 1.2B
- IPO Year
- CDTX 2015
- NFJ N/A
- Fundamental
- Price
- CDTX $63.31
- NFJ $12.67
- Analyst Decision
- CDTX Strong Buy
- NFJ
- Analyst Count
- CDTX 11
- NFJ 0
- Target Price
- CDTX $52.11
- NFJ N/A
- AVG Volume (30 Days)
- CDTX 659.9K
- NFJ 223.5K
- Earning Date
- CDTX 08-07-2025
- NFJ 01-01-0001
- Dividend Yield
- CDTX N/A
- NFJ 9.01%
- EPS Growth
- CDTX N/A
- NFJ N/A
- EPS
- CDTX N/A
- NFJ N/A
- Revenue
- CDTX $302,000.00
- NFJ N/A
- Revenue This Year
- CDTX N/A
- NFJ N/A
- Revenue Next Year
- CDTX N/A
- NFJ N/A
- P/E Ratio
- CDTX N/A
- NFJ N/A
- Revenue Growth
- CDTX N/A
- NFJ N/A
- 52 Week Low
- CDTX $10.14
- NFJ $10.45
- 52 Week High
- CDTX $66.95
- NFJ $12.86
- Technical
- Relative Strength Index (RSI)
- CDTX 70.66
- NFJ 54.74
- Support Level
- CDTX $60.71
- NFJ $12.64
- Resistance Level
- CDTX $66.95
- NFJ $12.90
- Average True Range (ATR)
- CDTX 4.25
- NFJ 0.15
- MACD
- CDTX -0.39
- NFJ -0.02
- Stochastic Oscillator
- CDTX 79.25
- NFJ 47.73
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.